BNY Capital Markets is in the market with a $1.35 billion credit backing CVS Corp.'s purchase of Eckerd from J.C. Penney. The deal comprises a five-year, $675 million facility and 364-day, $675 million facility. Pricing is based on a grid tied to ratings and is currently priced at 6.5 basis points on the 364-day and 8.5 basis points on the five year facility with 30 basis points all-in drawn and 35 basis points all-in drawn with utilization over 50%. Bank of America, Credit Suisse First Boston and Wachovia Securities are co-syndication agents on the deal. BNY is also leading a $1 billion bridge facility for CVS.